RxDoctor Payments Data

Shaun Bhatty, MD

Clinical Cardiac Electrophysiology · Zanesville, OHNPI 1316107154

Payments from drug & device makers

$8,283in general payments, 2019–2025

Across 291 payments — averaging $28.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$5K
  • Altathera Pharmaceuticals LLC$1K
  • Medtronic$875
  • Biosense Webster, Inc.$617
  • Atricure, Inc.$186
  • Philips North America LLC$109
  • plus $585 from 16 others

What the payments were for

  • Consulting fees$1,12514%
  • Travel & lodging$1,74321%
  • Food & beverage$5,41565%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,283 in reported general payments places this provider in the 25th percentile of 159 clinical cardiac electrophysiology providers in Ohio.

See all clinical cardiac electrophysiology providers in Ohio

Medicare billing

Part B allowed, 2024
$498,716
Medicare patients
1,381
Services billed
5,830

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban155$126,840
EliquisApixaban99$98,683
MultaqDronedarone Hcl20$15,545
Dofetilide50$13,725
Mexiletine Hcl29$3,984
Metoprolol Succinate211$2,735
Diltiazem 24hr Er (Cd)Diltiazem Hcl25$820
Amiodarone Hcl62$696
Digoxin20$385
Warfarin Sodium38$273
Dilt-XrDiltiazem Hcl13$263
Diltiazem 24hr Er (Xr)Diltiazem Hcl15$256
Metoprolol Tartrate45$139
Carvedilol40$88
ClopidogrelClopidogrel Bisulfate11$37

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$45$126,840155 claims
Sanofi-aventis U.S. LLCMultaq$58$15,54520 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 159 clinical cardiac electrophysiology providers in Ohio.

Other clinical cardiac electrophysiology in Zanesville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →